Pompili M

Department of Neurosciences, Mental Health and Sensory Organs, Faculty of Medicine and Psychology, Suicide Prevention Centre, Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa, 1035, Rome, 00189, Italy. Electronic address: maurizio.pompili@uniroma1.it.

4 papers · ORCID

ArticleKetamine

Beyond symptom reduction: Intranasal esketamine is associated with improved quality of life in treatment-resistant depression.

Pompili M, Sarubbi S, Di Biase G +5

Europe PMC2026

ArticleKetamine

Does Intranasal Esketamine Show Differential Efficacy with SSRIs versus SNRIs in Treatment-Resistant Depression?

Pompili M, Trocchia M, Di Biase G +5

Europe PMC2026

ArticleKetamine

Efficacy of Esketamine nasal spray in treatment-resistant depression: impact on depressive symptoms,hopelessness and suicide risk: A real-world evidence study

Pompili M, Trocchia M, Longhini L +5

Europe PMC2025

ArticleKetamine

Efficacy of Intranasal Esketamine in Treatment-Resistant Depression: A Six-Month Real-World Follow-Up Study of Depressive Symptoms, Hopelessness, and Suicide Risk.

Pompili M, Trocchia MA, Longhini L +5

Europe PMC2025